ELVN Next Earnings Date Notes

— Enliven Therapeutics (ELVN) is a clinical-stage biopharmaceutical company focused on developing small molecule therapies targeting cancer & rare diseases. The company's lead programs include ELVN-001, a potent, selective inhibitor of BCR-ABL for chronic myeloid leukemia (CML), and ELVN-002, aimed at targeting mutant HER2-driven cancers. As you prepare for the upcoming earnings call, it's critical to focus on the progress of their clinical trials—specifically enrollment rates, safety data, & preliminary efficacy signals from ongoing Phase 1/2 studies. Additionally, keep an eye on updates regarding partnerships, licensing activity, and the company's cash runway & burn rate, as these directly affect their ability to fund future research & development. Milestone achievements (such as regulatory submissions or advancement to later trial phases) and management's guidance on future timelines are also key metrics when evaluating Enliven's long-term potential. Listening for management commentary around competitive positioning, the differentiation of their candidates, & pipeline expansion opportunities can also provide crucial insights for gauging the overall trajectory of ELVN's business. The next projected earnings date for ELVN is 5/13/2026 after close (stay tuned for a confirmed earnings date once announced).

ELVN Next Earnings Date FAQ

On this page we presented the ELVN Next Earnings Date information for Enliven Therapeutics along with recent past earnings dates. For Q4 of 2025, ELVN reported earnings of -0.480/share, with the earnings report taking place on 3/3/2026. For Q3 of 2025, ELVN reported earnings of -0.320/share, with the earnings report taking place on 11/12/2025. For Q2 of 2025, ELVN reported earnings of -0.490/share, with the earnings report taking place on 8/13/2025. For Q1 of 2025, ELVN reported earnings of -0.570/share, with the earnings report taking place on 5/14/2025. For Q4 of 2024, ELVN reported earnings of -0.460/share, with the earnings report taking place on 3/13/2025. Based on these past earnings dates, the projected next earnings date for ELVN is 5/13/2026 after market close.

Any self directed investor who desires to keep tabs on the companies they own, can benefit from maintaining a calendar of next earnings dates for each stock in their porfolio, such as Enliven Therapeutics. When a company files its 10Q's with the SEC a mere four times a year, that certainly puts a lot of pressure on those four out of three hundred sixty five days! To say that earnings reports are important to Enliven Therapeutics shareholders would thus be an understatement! That's why we started the NextEarningsDate.com website, to make it easy for self directed investors to research Enliven Therapeutics next earnings dates as well as any other stock out there in our coverage universe, to see when the next ELVN earnings date — or any other stock — falls on the calendar. But we also present considerably more than just the next earnings date information alone, so we encourage you to explore the additional pages linked above to look up ELVN's past earnings as well, with pages for revenue and earnings history data, as well as earnings surprises as well. Thanks for visiting, and we hope you'll think of our site the next time you need to learn about the ELVN next earnings date.